image credit: Unsplash

FDA approves Pfizer/BioNTech and Moderna’s adapted COVID-19 vaccines

September 18, 2023


The updated vaccines more closely target current circulating variants

The US Food and Drug Administration (FDA) has granted approval for Pfizer/BioNTech and Moderna’s updated COVID-19 vaccines, to tackle currently circulating variants.

As previously recommended by the FDA, both vaccines have been adapted to closely target the XBB.1.5. Omicron variant by including a monovalent component.

Both companies’ mRNA vaccines are approved for use in individuals aged 12 years and older and authorised for emergency use in those aged six months to 11 years.

Read More on Pharma Times